CLO25-083: Immune-Related Adverse Events in Women With Early and Advanced Triple-Negative Breast Cancer Treated With Pembrolizumab: A Multi-Center Analysis
"CLO25-083: Immune-Related Adverse Events in Women With Early and Advanced Triple-Negative Breast Cancer Treated With Pembrolizumab: A Multi-Center Analysis" published on 28 Mar 2025 by National Comprehensive Cancer Network.
Authors
- Zeina Nahleh (ORCID: https://orcid.org/0000-0002-2489-1501)
- María Herrán
- Kaylee Sarna (ORCID: https://orcid.org/0000-0003-3533-111X)
- Rami Tfayli
- Theresa Abdo
- Ahmad Alhalabi
Institutions
- Cleveland Clinic Florida (US)
- Center for Clinical Research (United States) (US)
Publication Details
- Journal
- Journal of the National Comprehensive Cancer Network
- Published
- 2025-03-28
- DOI
- https://doi.org/10.6004/jnccn.2024.7190
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00